Medically Supervised Care Each session is administered under professional guidance for optimal safety and results
Semaglutide is prescribed for: Weight loss in adult patients with an initial body mass index (BMI) of 30 kg/m2 or greater (obesity) Weight loss in adult patients with an initial body mass index (BMI) of 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (hypertension, type 2 diabetes mellitus, or dyslipidemia) Weight loss in pediatric patients aged 12 years and older with an initial BMI at the 95th percentile or greater for age and sex (obesity) Reducing the risk of major adverse cardiovascular events (non-fatal myocardial infarction, CV death, or non-fatal stroke) in adults with cardiovascular disease and either obesity or overweight Treating noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH), formerly known as NASH, with moderate to advanced liver fibrosis (stages F2 to F3 fibrosis) in adults Patients taking semaglutide for any of these conditions, especially weight loss, are typically suggested to maintain a low-carb and low-fat diet
Typically, 'less than 50' might be a response, depending on the method used and the laboratory
For some people, hair only thins (this is very common for females), and for others, areas of complete baldness will occur if left untreated
Fast, friendly and my go to
By providing a 3-month supply of medication and all necessary supplies up front, patients stay fully equipped, avoid treatment gaps, and remain psychologically engaged in their journey leading to better outcomes and long-term success
